Management of spinal cord injury: Issues of debate

Abstract

Spinal cord injury is (SCI) a catastrophic event and one of the most common causes of severe disability and death following trauma. Successful outcome from a traumatic spinal cord injury (SCI) depends heavily upon the quality of the acute care rendered to the affected individual. In recent years, there have been significant advances in the acute ement of SCI. Although life expectancy has improved greatly in patients with SCI, there is still further room for improvement. Almost every aspect of the management of SCI is controversial, due in part to a lack of good-quality evidence. The current management strategies in the areas of prehospital care and transport, emergency room management, surgical considerations and pharmacotherapy are discussed.

Keywords

trauma - spinal cord injury - intensive care

• References

• 1 Figures from Mr El Masri based on. Frankel HL, Hancock DO, Hyslop G, Melzak J. et al The value of postural reduction in initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia 07 1969; 179-192
• 2 Bracken MB, Collins WF. et al Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251 1984; 45-52
• 3 Bracken MB. et al Methyl prednisolone or naloxone treatment after spinal cord injury: 1 – year follow up data – Results of the second national Acute Spinal Cord Injury Study. J Neurosurg 76 1992; 23-31
• 4 Bracken MB, Shepard MJ. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1 – year follow up – Results of the NASCIC Trial. J Neurosurg 89 1998; 699-706
• 5 Galandiuk S, Raque G, Appel S, Polk HCJr. The two edged sword of large-dose steroids for spinal cord trauma. Ann Surg 218 1993; 419-427
• 6 George ER. et al Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am Surg 61 1995; 659-664
• 7 Gerndt SJ, Rodriquez JL, Pawlik J W, Taheri PA, Wahl WL, Papadopoulos SM. Consequences of high dose steroid therapy for acute spinal cord injury. J Trauma 42 1997; 279-284
• 8 Pointillart V, Petitjean ME. et al Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord 38 2002; 71-76
• 9 Geisler FH, Dorsey FC, Coleman W P. GM -1 ganglioside in human spinal cord injury. Neurotrauma 09 1992; S517-S530
• 10 Hugenholtz H, Cass DE, Dvork MF, Fewer DH, Fox RJ. et al High dose methylprednisolone for acute closed spinal injury – only a treatment option. Can J Neurol Sci 29 2002; 227-235
• 11 Kate AJ Sansam. Controversies in the management of traumatic spinal cord injury. Clin Med 06 2006; 202-204
• 12 Yeo JD, Walsh J, Rutkowski S, Soden R. et al Mortality following spinal cord injury. Spinal Cord 36 1998; 329-336
• 13 DeVivo MJ, Black KJ, Stover SL. Causes of death during the first 12 years after spinal cord injury. Arch Phys Med Rehab 74 1993; 248-254
• 14 Krause JS. Accuracy of life expectancy estimates in life care plans: consideration of nonbioligical and non-injury factors. T o p Spinal Cord Injury Rehabil 07 2002; 59-68
• 15 Frankel HL, Coll JR, Charlifue SW, Whiteneck GG. et al Long term survival in spinal cord injury: a fifty year investigation. Spinal Cord 36 1998; 266-274
• 16 Short DJ, EL Masry WS, Jones PW. High dose methylprednisolone in the management of acute spinal cord injury: A systematic review from a clinical perspective. Spinal Cord 38 2002; 273-286